发明名称 (3-((Quinazolin-4-yl) amino)-1h-pyrazol-1-yl)acetamide derivatives and related compounds as aurora kinase inhibitors for the treatment of proliferative diseases such as cancer
摘要 Quinazoline derivatives of formula (I) for use in the treatment of proliferative diseases such as cancer and in the preparation of medicaments for use in the treatment of proliferative diseases, and to processes for their preparation, as well as pharmaceutical compositions containing, them as active ingredient. X is O or NR<SUP>6</SUP>; R<SUP>5 </SUP>is aryl or heteroaryl optionally substituted by 1, 2 or 3 substituents independently selected from halo, hydroxy, cyano, nitro, amino, C<SUB>1-4 </SUB>alkylamino, bis(C<SUB>1-4</SUB>alkyl)amino, C<SUB>1-4</SUB>alkyl, C<SUB>2-4 </SUB>alkenyl, C<SUB>2-4 </SUB>alkynyl, C<SUB>1-4 </SUB>alkoxy, C(O)NHR<SUP>17</SUP>, NHC(0)R<SUP>18 </SUP>and S(O)<SUB>p</SUB>R<SUP>19</SUP>where p is 0,1 or 2; The other substituents area as defined in claim 1.
申请公布号 US2006135541(A1) 申请公布日期 2006.06.22
申请号 US20050559328 申请日期 2005.12.01
申请人 ASTRAZENECA AB 发明人 MORTLOCK ANDREW A.;HERON NICOLA M.;JUNG FREDERIC H.;PASQUET GEORGES R.
分类号 A61K31/517;A61P43/00;C01B25/26;C07D403/12;C07D403/14;C07F9/6558 主分类号 A61K31/517
代理机构 代理人
主权项
地址